Are you sure you want to hide the widget forever? If you need it back, please clear your cookies.
Content
Colors
Navigation
Selected Language
English (United States)
All Languages
Accessibility Statement
Our Commitment to Accessibility
We are committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards to help users with various disabilities access our website effectively.
Compliance Status
Our website strives to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standards. We also aim to be compliant with the Americans with Disabilities Act (ADA) and the European Accessibility Act requirements. These guidelines and regulations explain how to make web content more accessible to people with a wide range of disabilities. We acknowledge that some aspects of our website may not yet achieve full compliance, and we are actively working to address these areas.
Accessibility Features Available
Our website implements the Accessibly App, which provides a variety of tools to enhance website accessibility:
Visual Adjustments
Bigger Text: Increase text size up to 3x for better readability (WCAG 2.1/1.4.4)
Bigger Cursor: Enhanced cursor visibility for easier navigation
Color Adjustments: Invert colors, adjust contrast, brightness, and saturation
Grayscale Mode: Convert website to grayscale for users with visual impairments
Hide Images: Reduce visual distractions for easier reading
Reading and Navigation Aids
Reading Line: Adds a guide line to help follow text
Reading Mask: Places a mask over text to isolate lines and enhance focus
Readable Fonts: Converts to highly legible fonts for better comprehension
Highlight Links: Makes links more prominent for easier navigation
Dyslexic Fonts: Special typography for users with dyslexia
Page Structure: Simplified layout options for easier navigation
Assistive Technologies
Keyboard Navigation: Full website control using keyboard (Tab, Shift+Tab, Enter)
Alt Text for Images: AI-generated image descriptions where manual ones aren't provided
Read Page Aloud: Text-to-speech functionality
Stop Animations: Pause motion content for users with vestibular disorders
Limitations and Feedback
Despite our best efforts to ensure accessibility, there may be some limitations. Content provided by third parties, user-generated content, or certain legacy pages may not be fully accessible. We are continuously working to improve our website's accessibility.
We welcome your feedback on the accessibility of our website. If you encounter any barriers or have suggestions for improvement, please contact us. We are committed to addressing these issues promptly.
Technical Information
The accessibility features on this website are provided through the Accessibly App, which utilizes several technologies including HTML, CSS, JavaScript, and various frameworks to enhance accessibility. Our implementation strives to be compatible with major screen readers and assistive technologies.
Legal Disclaimer
While we strive to adhere to WCAG 2.1 Level AA standards and provide accessible content, we cannot guarantee that our website will be accessible to all users under all circumstances. This website is provided 'as is' without any representations or warranties, express or implied.
In no event shall we be liable for any damages arising from or related to:
Inability to access or use the website
Any alleged non-compliance with accessibility laws or regulations
Any disruption or errors in the functionality of accessibility features
By using this website, you agree to hold us harmless from any claims related to website accessibility issues. We are committed to addressing accessibility barriers in good faith but cannot guarantee immediate resolution in all cases.
Contact Us
If you have any questions about our accessibility efforts or encounter any barriers while using our website, please contact us.
Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
April 11, 2022 08:00 am ETEstimated Read Time: 5 Minutes
Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. Fortunately, the U.S. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes.
Pennsylvania-based Groff North America is one of the companies that is getting a green light to experiment with the plant. The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. “We know cannabis has powerful potential medical effects. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.
Orthopedic spine surgeon Dr. Steve Groff established the company. He took inspired action to found Groff North America after years of acknowledging the plant’s therapeutic benefits. He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. territories.
“You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. It gets processed, it’s been FDA-approved,” Groff said to reporters as he compared the cannabis plant’s use to that of poppy flowers, which must first be prepared before they can be turned into opioid medications.
Federally Illegal Status of Cannabis Has Hindered Its Use in Medicine
Since cannabis is still a Schedule I substance under U.S. federal law, it has not yet been used in any commonly prescribed medicines. Fortunately, the brakes are gradually being lifted on research opportunities. This means that U.S. lawmakers could soon be appreciating the green plant for its remedial qualities and, as a direct effect, the plant’s federally illegal status could be lifted thereafter.
“We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.
Groff confirmed that it had completed its first batch of medicinal-grade cannabis for research purposes on Feb. 28. The company initiated the first legal transfer (as deemed by federal law) to the U.S. Drug Enforcement Agency (DEA). This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis.
“Lighting something on fire and passing it through your lungs is probably not the best way to treat that illness,” said Hodgin, who predicts that researchers will, someday, harbor solid proof of cannabis’ ability to treat widespread conditions like autism, anxiety, cancer, epilepsy, insomnia, inflammation, pain, Parkinson’s disease, PTSD, and Tourette syndrome.
See If You Qualify For Medical Marijuana -Select Your State!
Zelira Therapeutics is also pushing for the approval of cannabis-based medicines in the American market, one of which is a drug for insomnia. “I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “We could potentially develop north of 11,000 drugs that are cannabinoid-based. Is the future exciting? Absolutely.”
Another company that has been given the green light to produce cannabis for research is Castroville, CA-headquartered Biopharmaceutical Research Company. According to the company’s CEO, George Hodgin, “federally legal FDA- and DEA-approved cannabis-based drugs will absolutely upend the traditional pharmaceutical market.”
What Cannabis-Based Medicines Have Been Approved So Far?
The debate surrounding cannabis’ potentially therapeutic powers has ensued for decades. In particular, of all the components contained in the cannabis plant—including cannabinoids, terpenes, and flavonoids—the cannabis compound tetrahydrocannabinol (THC) has proven to harbor medicinal benefits when used in specific formulations.
Dronabinol (Marinol®) and nabilone (Cesamet®) have already been approved for prescription purposes by the U.S. Food and Drug Administration (FDA) when offered in pill form to cancer chemotherapy patients, as well as people who endure appetite loss and/or wasting syndrome caused by AIDS.
Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials. For example, the non-intoxicating compound cannabidiol (CBD) is combined with the psychotropic compound THC for the creation of an oral spray called nabiximols (Sativex®), which is currently being offered in Canada and a handful of European countries, including the United Kingdom.
CBD is also contained in another FDA-approved medicine called Epidiolex®. The pharmaceutical drug, which is created by British drug company GW Pharmaceuticals, is designed to ease the symptoms of Dravet syndrome and Lennox-Gastaut syndrome in young patients.
Challenges in Conducting Medical Cannabis Research Remain
The Controlled Substances Act of 1970 classified the plant as a Schedule I drug and, since this time, cannabis has remained an illegal substance under U.S. federal law. Because of these restrictive laws, thefederal government enforces harsh rules that make it impossible for researchers to investigate the pros, cons, and safety of cannabis products.
Until more research efforts take place, little will be known about cannabis’ suitability for treating patients who suffer from a wide range of diseases and illnesses. However, for more research to be conducted, policymakers must first dig a little deeper and garner sufficient evidence of the plant’s worthiness to be rescheduled under U.S. federal law, from which point, informed choices can be made about the use of cannabis and cannabinoids.
Bethan Rose is a cannabis advocate, writer and traveler with no permanent address. Currently based in Bali, she can usually be found curating cannabis content on her hammock.
Thank you for sharing this, there needs to be more awareness around cannabis being used as medicine. It’s also a nice alternative to alcohol, which could have disastrous effects if abused.
>>You don’t take that opium poppy and ask a patient to rub it on their lip for morphine.
Interesting…maybe you SHOULD suggest that. Then people can grow poppies in their gardens and take care of themselves and humanity will suffer less pain.
If pain is an aspect of your cannabis journey, you might be interested in a Green Dragon tincture. This homemade creation will not turn you into a magic dragon, but it could make you feel on top of the world if you are dealing with chronic pain. Pain can slow us down. When the body…
What gives cannabis its powerful effects, rich aroma, and frosty appearance? The answer lies in crystal-like structures called trichomes that cover the surface of cannabis flowers. This is where the cannabis cultivation magic happens because they produce and store the majority of compounds responsible for the plant’s potency, flavor, and therapeutic benefits. Trichomes are the…
Sometimes, your urine has a strange, weed-like, or other abnormal smell, and you might not be sure what’s causing it. This common experience often leads to online searches driven by curiosity or concern about potential health issues. This article explores some of the most common reasons behind a cannabis-like urine odor and other types of…
As of April 2025, 39 states, three U.S. territories, and the District of Columbia have some form of medical cannabis program. Each program is unique, and some states only offer low-THC medical cannabis for those who qualify. But what does “low-THC cannabis” really mean? And what products can patients in these states actually purchase? We’re…
According to data recently released by Human Rights Watch, between 2002 and 2020, just over 127,000 people were deported for cannabis-related offenses. This number accounts for 35% of all deportations where drug-related charges were the most serious offense. Notably, this time includes several years when cannabis was illegal on both the state and federal levels….
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.